-
-
Litigation regarding e-mail in health care already has reached the trial level, says Edward C. Mintzer Jr., a partner with the law firm of Rawle & Henderson in Philadelphia.
-
With more and more health information being transferred electronically, risk managers must be more cautious than ever about complying with the Health Insurance Portability and Accountability Act (HIPAA), says Cheryl Camin, JD, an attorney on the HIPAA practice team at the Dallas law firm of Gardere Wynne.
-
More than 90% of surveyed physicians in Pennsylvania reported defensive medicine practices such as overordering of diagnostic tests, unnecessary referrals, and avoidance of high-risk patients, according to a recent study.
-
Errors in drug ordering, dosage, and monitoring that may have serious consequences for patients persist in hospitals even after the adoption of computerized medication systems, according to a recent study.
-
By Jan J. Gorrie, Esq.
Buchanan Ingersoll PC Tampa, FL
News: Prior to surgery, a patient informed the hospital of her allergy to latex. Despite this warning, a latex catheter was used and she subsequently developed interstitial cystitis. She brought suit against the health care providers and was awarded $3.75 million in damages.
-
Recent revelations that hundreds of HIV-positive foster children may have been signed up for clinical trials without advocates assigned to ensure their safety have stirred the latest controversy regarding pediatric clinical research.
-
The largest study yet of public fears about genetic discrimination found that 40% of people undergoing testing for a particular genetic disease were concerned that their participation could affect future access to insurance.
-
The new public outreach campaign by the OHRP is a much-needed step in the right direction, say many clinical researchers. But the campaigns centerpiece an educational pamphlet designed to answer basic questions about research participation is leaving nonclinical researchers feeling left out in the cold.
-
Last year, South Korean researcherWoo Suk Hwang and colleagues at Seoul National University stunned the world with news first published in Science on-line that they had developed stem cells from a cloned human embryo, using somatic-cell nuclear transfer.
